Moderna COVID-19 vaccine doubles level of antibodies versus Pfizer shot: study

Moderna’s COVID-19 vaccine more than doubled the level of antibodies compared to the Pfizer vaccine, according to a study of healthcare workers in Belgium, researchers found.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.